CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7 • T: 604-874-4944 F: 604-874-4378 E: [email protected] W: www.cttcanada.org
Preliminary ProgramANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA
2020
Québec City, QCJUNE 22-25, 2020
CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7 • T: 604-874-4944 F: 604-874-4378 E: [email protected] W: www.cttcanada.org
Preliminary Program2020
Québec City, QCJUNE 22-25, 2020
ANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA 2
PRE-CONFERENCE DAY – MONDAY, JUNE 22, 2019 (DELTA HOTELS QUEBEC)Registration
10:30am – 4:00pm
BMT/CT101A: HEALTH CARE PROFESSIONALSOpening Remarks: Donna Wall, MD, Kristjan Paulson, MD The Graft: It Is About the Cells – Nicole Prokopishyn, PhD
Comorbidity Scoring and Fitness – Mahmoud Elsawy, MD, MSc
BMT/CT101B: PATIENTS, FAMILIES, CAREGIVERS*CHAIRS: Lindsay Thompson, Peter MaloneOpening Remarks: Lindsay Thompson, Peter MaloneVision for The Future: Update on Treatment Options – Guy Cantin, MD (TENTATIVE)
Update on Treatment Options for GvHD – Genevieve Gallagher, MD (TENTATIVE)
12:15pm – 1:30pm Lunch
BMT/CT101A: CONTINUES
Decision Process in Preparative Regimen selection – Michael Kennah, MD, MSc
GVHD Prophylaxis Post-HSCT: Are We Over Immunosuppressing? – Jonas Mattsson, MD, PhD
Closing Remarks and Evaluation: Donna Wall, MD, Kristjan Paulson, MD
BMT/CT101B: CONTINUES
Access to New Medication Used in the Treatment of GvHD – Nikki Blosser, BSc. Pharm, ACPR (TENTATIVE)
Closing Remarks: Lindsay Thompson, Peter Malone
2:00pm – 5:00pm CTTC LABORATORY: WET LAB – HÉMA-QUÉBEC4:00pm – 4:30pm Health Break
4:30pm – 7:00pm PATIENT AND CAREGIVER SYMPOSIUM*CHAIRS: Lindsay Thomspon, Peter MaloneRecycling Tools in the Toolbox – Leeza Friedman-Prokopishyn, MSW, RCSW
7:00pm – 8:00pm PATIENT AND CAREGIVER DINNER
6:00pm – 9:00pm PRESIDENTIAL SYMPOSIUM: EVOLVING NATIONAL STRATEGIES FOR CAR-T
DAY 1 – TUESDAY, JUNE 23, 2020 (QUEBEC CITY CONVENTION CENTRE)
7:00am – 8:45am CORPORATE SYMPOSIUM WITH BREAKFAST
Registration
Speaker Services
* simultaneous translations services available
CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7 • T: 604-874-4944 F: 604-874-4378 E: [email protected] W: www.cttcanada.org
Preliminary Program2020
Québec City, QCJUNE 22-25, 2020
ANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA 3
DAY 1 – TUESDAY, JUNE 23, 2020 (QUEBEC CITY CONVENTION CENTRE)
9:00am – 12:15pm SESSION 1: HANS MESSNER LECTURESHIP*CHAIR: Donna Wall, MD and Guy Cantin, MD
Welcome to the Annual Conference – Donna Wall, MD and Guy Cantin, MD
Hans Messner Lectureship: Allogenic Transplants in MDS and High Risk AML – Nicolaus Kröger, MD
Approaches in MDS and AML for Patients Not-Eligible for Transplantation – Julie Bergeron, MD
10:15am – 10:45am Health Break
Hans Messner New Investigator Award 2019: Longitudinal MBW in Pediatric BMT Patient – Jonathan Rayment, MDCM, MSc, FRCP(C)
12:15pm – 1:45pm CORPORATE SYMPOSIUM WITH LUNCH
2:00pm – 5:00pm SESSION 2A: SCIENCE* CHAIR: Frédéric Barabé, MD, FRCPC
Till & McCulloch Lectureship: Guy Sauvageau, MD
SESSION 2B: LABORATORYCHAIR: Diane Fournier, PhD
Advanced Cell Therapies and the Role of Canadian CT Labs – Martin Giroux, PhD
SESSION 2C: NURSING* CHAIR: Stephanie Duguay, IPA, CSIO(C)
How to Inform and Educate Patients (FR) – Sarah-Judith Breton, RN
SESSION 2D: PHARMACY CHAIR: Yves Rousseau, B Pharm, MSc, BCOP
Transplants for SCID and Other Autoimmune Diseases – Esther Jadusingh, BSc, BScPharm, ACPR
3:00pm – 3:30pm Health Break
SESSION 2A: CONTINUES
Mechanisms of Leukemia Immune Evasion and Relapse after Hematopoietic Stem Cell Transplantation – Luca Vago, MD (TENTATIVE)
Gene Therapy for Immune Deficiency – Donald Kohn, MD
SESSION 2B: CONTINUES
Laboratory Nightmares: Past Incidents and Actions to Prevent Future Occurrences – Jelena Holovati, MLT, PhD, and Mike Halpenny, MLT CliniMACs Procedure: Understanding and Optimizing Cell Recoveries – Susan Berrigan, MLT
SESSION 2C: CONTINUES
Complex Pain Management in Pediatric Cell Therapy: IV Dexmedetomidine Outside PICU at CHU Sainte Justine – Julie Paquette RN, MSc and Martine Therrien RN, BSc inf
Out-Patient Transplant Setting: The Role of the Nurse – Laurie Ann Holmes, RN, BScN, CON(C), CHPCN(C)
SESSION 2D: CONTINUES
Access to New Medication Used in the Treatment of GvHD – Nikki Blosser, BSc, BScPharm, ACPR Outpatient Stem Cell Transplant: the Role of the Pharmacist –Philippe Bouchard, BPharm, MSc, BCOP, & Lina Ho, BPharm
5:00pm – 6:00pm WELCOME RECEPTION
6:30pm – 8:00pm CORPORATE SYMPOSIUM WITH DINNER
* simultaneous translations services available
CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7 • T: 604-874-4944 F: 604-874-4378 E: [email protected] W: www.cttcanada.org
Preliminary Program2020
Québec City, QCJUNE 22-25, 2020
ANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA 4
DAY 1 – TUESDAY, JUNE 23, 2020 (QUEBEC CITY CONVENTION CENTRE)
8:00pm – 9:00pm COMMUNITIES OF PRACTICE: NETWORKING SESSIONS Nursing Networking Session Pharmacist Networking Session Administrators and BMT Coordinators Networking Session Laboratory Networking Session Advanced Practitioners Networking Session
DAY 2 – WEDNESDAY, JUNE 24, 20207:00am – 8:45am CORPORATE SYMPOSIUM WITH BREAKFAST
Registration
Speaker Services
9:00am – 10:00amSESSION 3: FRED SAUNDERS LECTURESHIP* CHAIR: Pierre Teira, MD, MSc
Fred Saunders Lectureship: Gene Therapy For Hemoglinopathy – Marina Cavazzana, MD
10:00am – 10:15am Health Break
10:15am – 11:15am CTTC ANNUAL GENERAL MEETING
11:30am – 1:00pm CORPORATE SYMPOSIUM WITH LUNCH
1:15pm – 3:15pm
SESSION 4: CAR-T AND THE FUTURE OF CELL THERAPY*State of the Nation of CAR-T in Canada – Isabelle Fleury, MD
Advancing Cell Therapies – Cameron Turtle (TENTATIVE)
CAR-NK Cells – Speaker TBD
3:15pm – 3:30pm Health Break
3:30pm – 4:30pm POSTER ABSTRACT PRESENTATIONS
4:30pm – 5:30pm ORAL ABSTRACT PRESENTATIONS ORAL ABSTRACT PRESENTATIONS
7:00pm Onwards GALA DINNER: MUSÉE DE LA CIVILIZATION
* simultaneous translations services available
CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7 • T: 604-874-4944 F: 604-874-4378 E: [email protected] W: www.cttcanada.org
Preliminary Program2020
Québec City, QCJUNE 22-25, 2020
ANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA 5
Cell Therapy Transplant Canada (CTTC) is pleased to partner with Héma-Québec for Canadian Innovation Day, hosted by the World Marrow Donor Association (WMDA)
DAY 3 – THURSDAY, JUNE 25, 2020: CANADIAN INNOVATION DAYRegistration
Speaker Services
7:00am – 8:30am CORPORATE SYMPOSIUM WITH BREAKFAST
8:45am – 9:55am(Room 200AB)
SESSION 5: FAIR FIGHT FOR ALLIntroduction: Canadian Innovation Day – Jean-Sébastien Delisle, MD, PhD
Swab The World Foundation – Mai Duong & Christiane Rochon First Nations Project (Héma-Québec) – Nadia Baillargeon Panel Discussion and Q&A
9:55am – 10:10am Health Break
10:10am – 11:35am(Room 200A)
SESSION 6: GENE EDITINGCRISPR – Brief History and Current Application – Sylvain Moineau, PhD Blood Stem Cell Genome Editing: CCR5 – Ellie Haddad, MD (Tentative)
Panel Discussion: Ethical Considerations
11:15am – 12:30pm Lunch
12:30am – 2:15pm (Room 200A)
ENABLING INNOVATIONCord Blood Expansion UM171: How will it Affect CBU Selection – Sandra Cohen, MD
Haplo Transplantation: ATIR – Denis-Claude Roy, MD (TENTATIVE)
More than Minimally Manipulated T-Cell Immunotherapies – Jean-Sébastien Delisle, MD, PhD
2:15pm – 2:30pm Health Break (Sponsored by Ontime Courier – Héma-Québec/WMDA)
2:30pm – 5:00pm
ENABLING INNOVATIONTransplantation in MS – Harry Atkins, MD CHUM Innovative Projects – Réjean Lapointe, PhD BioCANRx: Canadian CARs – Kevin Hay, MD (TENTATIVE)
Adoptive Transfer of Plasmacytoid Dendritic Cells to Increase GVL Effect – Michel Duval, MD
6:00pm – 9:00pm CTTC OFFSITE NETWORKING EVENT (LE MONASTÈRE DES AUGUSTINES)
Top Related